These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

490 related items for PubMed ID: 8053391

  • 41. Effects of 42 months of GH treatment on bone mineral density and bone turnover in GH-deficient adults.
    Välimäki MJ, Salmela PI, Salmi J, Viikari J, Kataja M, Turunen H, Soppi E.
    Eur J Endocrinol; 1999 Jun; 140(6):545-54. PubMed ID: 10377504
    [Abstract] [Full Text] [Related]

  • 42. Changes in bone mineral density and markers of bone remodeling during lactation and postweaning in women consuming high amounts of calcium.
    Cross NA, Hillman LS, Allen SH, Krause GF.
    J Bone Miner Res; 1995 Sep; 10(9):1312-20. PubMed ID: 7502702
    [Abstract] [Full Text] [Related]

  • 43. Vitamin D levels and bone turnover in epilepsy patients taking carbamazepine or oxcarbazepine.
    Mintzer S, Boppana P, Toguri J, DeSantis A.
    Epilepsia; 2006 Mar; 47(3):510-5. PubMed ID: 16529614
    [Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45. Bone mineral density and calcium regulating hormones in patients with inflammatory bowel disease (Crohn's disease and ulcerative colitis).
    Scharla SH, Minne HW, Lempert UG, Leidig G, Hauber M, Raedsch R, Ziegler R.
    Exp Clin Endocrinol; 1994 Mar; 102(1):44-9. PubMed ID: 8005208
    [Abstract] [Full Text] [Related]

  • 46. Relationship between bone formation markers bone alkaline phosphatase, osteocalcin and amino-terminal propeptide of type I collagen and bone mineral density in elderly men. Preliminary results.
    Lumachi F, Orlando R, Fallo F, Basso SM.
    In Vivo; 2012 Mar; 26(6):1041-4. PubMed ID: 23160690
    [Abstract] [Full Text] [Related]

  • 47. Long-term anticonvulsant therapy leads to low bone mineral density--evidence for direct drug effects of phenytoin and carbamazepine on human osteoblast-like cells.
    Feldkamp J, Becker A, Witte OW, Scharff D, Scherbaum WA.
    Exp Clin Endocrinol Diabetes; 2000 Mar; 108(1):37-43. PubMed ID: 10768830
    [Abstract] [Full Text] [Related]

  • 48. Osteopenia in insulin-dependent diabetes mellitus; prevalence and aspects of pathophysiology.
    Kemink SA, Hermus AR, Swinkels LM, Lutterman JA, Smals AG.
    J Endocrinol Invest; 2000 May; 23(5):295-303. PubMed ID: 10882147
    [Abstract] [Full Text] [Related]

  • 49. Bone mineral density and body composition before and during treatment with gonadotropin-releasing hormone agonist in children with central precocious and early puberty.
    Boot AM, De Muinck Keizer-Schrama S, Pols HA, Krenning EP, Drop SL.
    J Clin Endocrinol Metab; 1998 Feb; 83(2):370-3. PubMed ID: 9467543
    [Abstract] [Full Text] [Related]

  • 50. Procollagen type I carboxy-terminal extension peptide in serum as a marker of collagen biosynthesis in bone. Correlation with Iliac bone formation rates and comparison with total alkaline phosphatase.
    Parfitt AM, Simon LS, Villanueva AR, Krane SM.
    J Bone Miner Res; 1987 Oct; 2(5):427-36. PubMed ID: 3455625
    [Abstract] [Full Text] [Related]

  • 51. Bone mineral density and abstention-induced changes in bone and mineral metabolism in noncirrhotic male alcoholics.
    Laitinen K, Lamberg-Allardt C, Tunninen R, Härkönen M, Välimäki M.
    Am J Med; 1992 Dec; 93(6):642-50. PubMed ID: 1466360
    [Abstract] [Full Text] [Related]

  • 52. PICP as bone formation and NTx as bone resorption marker in patients with chronic renal failure.
    Franke S, Lehmann G, Abendroth K, Hein G, Stein G.
    Eur J Med Res; 1998 Feb 21; 3(1-2):81-8. PubMed ID: 9512973
    [Abstract] [Full Text] [Related]

  • 53. Parenteral pamidronate prevents thyroid hormone-induced bone loss in rats.
    Rosen HN, Sullivan EK, Middlebrooks VL, Zeind AJ, Gundberg C, Dresner-Pollak R, Maitland LA, Hock JM, Moses AC, Greenspan SL.
    J Bone Miner Res; 1993 Oct 21; 8(10):1255-61. PubMed ID: 8256663
    [Abstract] [Full Text] [Related]

  • 54. Combination of radiological and biochemical methods to assess bone mineral density of mandible in fully edentulous patients after chemotherapy: a 5-year prospective study.
    Loo WT, Jin LJ, Cheung MN, Chow LW, Wang M.
    Expert Opin Investig Drugs; 2010 Apr 21; 19 Suppl 1():S109-15. PubMed ID: 20374022
    [Abstract] [Full Text] [Related]

  • 55. Currently used growth-promoting treatment of children results in normal bone mass and density. A prospective trial of discontinuing growth hormone treatment in adolescents.
    Fors H, Bjarnason R, Wirént L, Albertsson-Wikland K, Bosaeust L, Bengtsson BA, Johannsson G.
    Clin Endocrinol (Oxf); 2001 Nov 21; 55(5):617-24. PubMed ID: 11894973
    [Abstract] [Full Text] [Related]

  • 56. Assessment of bone mineral density and markers of bone turnover in children under long-term oral anticoagulant therapy.
    Avgeri M, Papadopoulou A, Platokouki H, Douros K, Rammos S, Nicolaidou P, Aronis S.
    J Pediatr Hematol Oncol; 2008 Aug 21; 30(8):592-7. PubMed ID: 18799935
    [Abstract] [Full Text] [Related]

  • 57. The effects of prolonged growth hormone replacement on bone metabolism and bone mineral density in hypopituitary adults.
    Beshyah SA, Kyd P, Thomas E, Fairney A, Johnston DG.
    Clin Endocrinol (Oxf); 1995 Mar 21; 42(3):249-54. PubMed ID: 7758229
    [Abstract] [Full Text] [Related]

  • 58. The effect of short- and long-term growth hormone treatment on bone mineral density and bone metabolism of prepubertal children with idiopathic short stature: a 3-year study.
    Lanes R, Gunczler P, Esaa S, Weisinger JR.
    Clin Endocrinol (Oxf); 2002 Dec 21; 57(6):725-30. PubMed ID: 12460321
    [Abstract] [Full Text] [Related]

  • 59. Effect of long-term growth-hormone substitution therapy on bone mineral density and parameters of bone metabolism in adult patients with growth hormone deficiency.
    Kotzmann H, Riedl M, Bernecker P, Clodi M, Kainberger F, Kaider A, Woloszczuk W, Luger A.
    Calcif Tissue Int; 1998 Jan 21; 62(1):40-6. PubMed ID: 9405732
    [Abstract] [Full Text] [Related]

  • 60. Effect of oxcarbazepine on bone mineral density and biochemical markers of bone metabolism in patients with epilepsy.
    Koo DL, Hwang KJ, Han SW, Kim JY, Joo EY, Shin WC, Lee HW, Seo DW, Hong SB.
    Epilepsy Res; 2014 Mar 21; 108(3):442-7. PubMed ID: 24507862
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 25.